Sarantel’s revolutionary ceramic filtering antennas offer dramatically improved performance over existing antenna designs, resulting in a clearer signal, better range and a 90 per cent reduction in the amount of signal radiation absorbed by the body.
All RNS Press Releases RNS Release - Holding(s) in Company
9th Nov 2011, 6:11 pm
RNS Number : 8257R
Sarantel Group PLC
09 November 2011
For filings with the FSA include
the annex For filings with issuer exclude the annex |
|
|
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
|
|
|
|
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii | SARANTEL GROUP PLC 'A' |
|
An acquisition or disposal of voting rights | X |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments |
|
An event changing the
breakdown of voting rights |
|
Other (please
specify): |
|
|
3. Full name of person(s) subject to the
notification obligation: iii | HARGREAVE HALE LIMITED |
4. Full name
of shareholder(s)
(if different from 3.):iv | DISCRETIONARY
CLIENTS |
5. Date of the transaction and date on
which the threshold is crossed or
reached: v | 08 NOVEMBER 2011 |
6. Date on which issuer notified: | 09 NOVEMBER 2011 |
7. Threshold(s) that is/are crossed or
reached: vi, vii | 5% |
| | | | | |
8. Notified details: |
A: Voting rights attached to shares viii, ix |
Class/type of
shares
if possible using
the ISIN CODE
| Situation previous
to the triggering
transaction | Resulting situation after the triggering
transaction |
Number
of
Shares | Number
of
Voting
Rights | Number
of shares | Number of voting
rights | % of voting rights
x |
Indirect | Direct xi | Indirect xii | Direct | Indirect |
GB00B065J785 | 41,335,000 | 41,335,000 | 43,335,000 |
| 43,335,000 |
| 5.2181% |
|
|
B: Qualifying Financial Instruments |
Resulting situation after the triggering transaction |
Type of
financial
instrument | Expiration
date xiii | Exercise/
Conversion Period xiv | Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted. | % of voting
rights |
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv,
xvi |
Resulting situation after the triggering transaction |
Type of financial
instrument | Exercise price | Expiration date xvii | Exercise/
Conversion period xviii | Number of voting rights
instrument refers to | % of voting rights xix, xx |
|
|
|
| | Nominal | Delta |
|
|
|
Total (A+B+C) |
Number of voting
rights | Percentage of voting rights |
43,335,000 | 5.2181% |
| | | | | | | | | | | | | | | | |
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: xxi |
34,500,000 of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd for whom Hargreave Hale Ltd manages the investments on a discretionary basis. The remaining shares are held for other Discretionary clients.
|
|
Proxy
Voting: |
10. Name of the proxy holder: |
|
11. Number of voting rights proxy holder will cease
to hold: |
|
12. Date on which proxy holder will cease to hold
voting rights: |
|
|
13. Additional information:
|
|
14. Contact name: | David Clueit |
15. Contact
telephone number: | 01253 754739 |
| | |
This information is provided by RNS
The company news service from the London
Stock Exchange
END
HOLEAPFNEENFFFF
No investment advice
The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
